Effects of Metabolism-Related Indicators on Nonalcoholic Fatty Liver Disease in Nonobese Population Based on the National Health and Nutrition Examination Survey
Table 1
Characteristics of the study population by nonobese NAFLD status.
Variables
Total
Non-NAFLD
NAFLD
value
N
904
788 (87.16%)
116 (12.83%)
Age (years)
42.85 ± 0.86
41.27 ± 0.88
57.70 ± 1.59
<0.001
BMI (Kg/m2)
22.07 ± 0.08
21.96 ± 0.08
23.06 ± 0.18
<0.001
WHR
0.86 ± 0.01
0.85 ± 0.01
0.92 ± 0.01
<0.001
SBP (mmHg)
117.49 ± 0.84
116.76 ± 0.83
124.39 ± 1.82
<0.001
DBP (mmHg)
69.48 ± 0.52
69.18 ± 0.54
72.23 ± 0.82
<0.001
Comorbidity
Hypertension
<0.001
Yes
738
666 (80.04%)
72 (5.94%)
No
166
122 (10.35%)
44 (3.66%)
T2DM
<0.001
Yes
845
752 (88.59%)
93 (7.81%)
No
59
36 (1.80%)
23 (1.78%)
TC (mg/dl)
182.09 ± 2.08
180.60 ± 2.45
196.17 ± 6.52
<0.001
HDL-c (mg/dl)
61.73 ± 0.77
61.63 ± 0.84
62.75 ± 2.65
<0.001
TG (mg/dl)
98.25 ± 2.38
93.54 ± 2.15
142.56 ± 12.31
<0.001
HbA1c (%)
5.38 ± 0.03
5.32 ± 0.01
5.98 ± 0.19
<0.001
Uric acid (μmol/L)
278.67 ± 3.50
274.80 ± 3.34
315.19 ± 10.20
<0.001
Weighted mean ± SE for continuous variables or n and weighted proportion for categorical variables. BMI, body mass index; WHR, waist-to-hip ratio; SBP, systolic blood pressure; DBP, diastolic blood pressure; TG, triglyceride; TC, total cholesterol; BMI, body mass index; T2DM, type 2 diabetes mellitus; HDL-c, high-density lipoprotein cholesterol; NAFLD, nonalcoholic fatty liver disease.
